MétaCan
Menu
← Back to cohort
Record W4397044190 · doi:10.1681/asn.20233411s1862b

Empagliflozin in Patients with Acute Heart Failure and Diuretic Resistance: Preliminary Data from the DRIP-AHF-1 Trial

2023· article· en· W4397044190 on OpenAlexaff
Pedro Marques, Abhinav Sharma, Thomas A. Mavrakanas

Bibliographic record

VenueJournal of the American Society of Nephrology · 2023
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsMcGill University Health Centre
Fundersnot available
KeywordsEmpagliflozinDiureticMedicineHeart failureCardiologyInternal medicineIntensive care medicineEndocrinologyDiabetes mellitus

Abstract

fetched live from OpenAlex

Background: Diuretic resistance is common in acute heart failure and associated with poor clinical outcomes. Chronic kidney disease (CKD) is a major determinant of diuretic resistance. Association of furosemide with sodium-glucose cotransporter 2 inhibitors can potentially overcome diuretic resistance in acute heart failure patients with CKD. Methods: This is a prospective, single-arm, observational, open-label clinical trial. Patients admitted with acute heart failure with estimated glomerular filtration rate (eGFR) of 15-45mL/min/1.73m2 and diuretic resistance, defined as a urinary output (UO)<300mL in the 2 hours post 1-1.5mg/kg IV furosemide, were recruited. These patients received 25mg of empagliflozin 2 hours post a second IV furosemide bolus of 1-1.5mg/kg, administered at least 5 hours after the initial furosemide bolus. Primary outcome is the 3-hour UO post furosemide+empagliflozin on the first day of the study, compared with furosemide alone. Secondary outcomes include fractional excretion of sodium (FENa) and total urinary sodium excretion. Results: From 32 patients screened, 6 patients met inclusion criteria and consented to participate. Median age was 80 (75-84) years, 67% were male, median ejection fraction was 40 (40-55) % and median baseline eGFR 18 (17-25) mL/min/1.73m2. All patients had a strong response to furosemide after empagliflozin administration (Table) Conclusions: Our preliminary data shows that empagliflozin at a dose of 25mg, when added to high dose IV furosemide in patients with acute heart failure, low eGFR and diuretic resistance, is capable of increasing urinary output and urinary sodium excretion. Funding: Private Foundation Support - Data for the primary and secondary outcomes Patient number UO 3h post FST (mL) UO 3h post Empa+FST (mL) FENa 3h post FST (%) FENa 3h post Empa+FST (%) Na excretion 3h post FST (mmol) Na excretion 3h post Empa+FST (mmol) #1 215 290 4.7 7.6 14.4 22.0 #2 345 650 2.3 8.5 19.7 57.9 #3 290 515 7.2 11.3 27.8 55.6 #4 490 775 8.0 11.4 54.8 88.4 #5 80 310 3.3 6.4 6.0 27.0 #6 340 605 5.0 12.4 30.9 67.8 Empa - Empagliflozin; FENa - Fractional excretion of sodium; FST - Furosemide stress test; Na - Sodium; UO - Urinary output

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.004
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.270
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicDiabetes Treatment and Management→French-language works237,207→